No Data
No Data
Mizuho Securities Maintains Neurocrine Biosciences(NBIX.US) With Hold Rating
Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking. -- Barrons.com
Catalyst Watch: Spotlight on Micron, Southwest Airlines, and FOMC Speakers
Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit
Neurocrine Biosciences Executive Sells Over $420k in Company Stock
Express News | Cantor Fitzgerald Reiterates Overweight on Neurocrine Biosciences, Maintains $155 Price Target
Tonyco OP : Prolly 120 entry for long, else short now